BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
834 results:

  • 1. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
    Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
    PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
    Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
    Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
    Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
    Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
    BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of
    Santos KVGD; da Silva RLM; Sarmento ACA; Medeiros KS; Pessoa RL; Dantas DV; Dantas RAN
    Integr Cancer Ther; 2023; 22():15347354231220608. PubMed ID: 38140826
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KTt-45, a T-type calcium channel blocker, acts as an anticancer agent by inducing apoptosis on HeLa cervical cancer cell line.
    Du NH; Ngoc TTB; Cang HQ; Luyen NTT; Thuoc TL; Le Quan T; Thao DTP
    Sci Rep; 2023 Dec; 13(1):22092. PubMed ID: 38086845
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pitavastatin induces caspase-mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line.
    Hacıseyitoğlu AÖ; Doğan TÇ; Dilsiz SA; Canpınar H; Eken A; Bucurgat ÜÜ
    J Appl Toxicol; 2024 Apr; 44(4):623-640. PubMed ID: 38053498
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical cancer: Genomic Profiling Relating to Clinical Efficacy.
    Zhang Q; Zhang J; Liu Z; Wang J; Wang F; Wang T; Shi F; Su J; Zhao Y
    Drug Des Devel Ther; 2023; 17():3507-3522. PubMed ID: 38046281
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
    Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
    Li M; Zheng W
    Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Characteristics and outcomes of surgically staged multiple classifier endometrial cancer.
    Bogani G; Betella I; Multinu F; Casarin J; GhezzI F; Sorbi F; VizziellI G; Petrillo M; Cianci S; Berretta R; PaolinI B; FanfanI F; De Vitis L; Scambia G; Mariani A; Colombo N; Raspagliesi F
    Eur J Surg Oncol; 2024 Jan; 50(1):107269. PubMed ID: 37984242
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
    Spencer JC; Burger EA; Campos NG; Regan MC; Sy S; Kim JJ
    J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):188-195. PubMed ID: 37947333
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
    André T; Berton D; Curigliano G; Sabatier R; Tinker AV; Oaknin A; Ellard S; de Braud F; Arkenau HT; Trigo J; Gravina A; Kristeleit R; Moreno V; Abdeddaim C; Vano YA; Samouëlian V; Miller R; Boni V; Torres AA; Gilbert L; Brown J; Dewal N; Dabrowski C; Antony G; Zografos E; Veneris J; Banerjee S
    JAMA Netw Open; 2023 Nov; 6(11):e2341165. PubMed ID: 37917058
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in uterine Endometrioid Carcinoma.
    Adachi S; Kimata JI; Hanami K; Adachi K; Igarashi T; Liang SG; Ishida Y; Fujino T; Yamazaki K
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):24-31. PubMed ID: 37859432
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
    Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
    [No Abstract]    [Full Text] [Related]  

  • 17. Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa.
    Denny L; Saidu R; Boa R; Mbatani N; Castor D; Moodley J; Kuhn L
    Sci Rep; 2023 Sep; 13(1):16182. PubMed ID: 37758811
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Disparities in Timeliness of Endometrial cancer Care: A Scoping Review.
    Najor A; Melson V; Lyu J; Fadadu P; Bakkum-Gamez J; Sherman M; Kaunitz A; Connor A; Destephano C
    Obstet Gynecol; 2023 Oct; 142(4):967-977. PubMed ID: 37734095
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
    Mungo C; Osongo CO; Ambaka J; Omoto J; Cohen CR
    Int J Cancer; 2023 Dec; 153(12):1971-1977. PubMed ID: 37715464
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
    Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 42.